Neurocognitive outcomes in pediatric HIV

Mental Retardation and Developmental Disabilities Research Reviews

Volumn 12, Issue 3, 2006, Pages 223-228

  Willen, Elizabeth J ^a,b,c  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c Department of Pediatrics ^*  (United States)

Author keywords

Neurocognitive; Neurodevelopmental delays; Perinatal HIV infection; Vertical HIV infection

Indexed keywords

BRAIN DEVELOPMENT; CHILD; CHILDHOOD DISEASE; COGNITIVE DEFECT; DISEASE ASSOCIATION; DISEASE SEVERITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; OUTCOMES RESEARCH; PRIORITY JOURNAL; REVIEW; RISK FACTOR; UNITED STATES; VERTICAL TRANSMISSION;

AIDS DEMENTIA COMPLEX; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHILD; CHILD, PRESCHOOL; COGNITION DISORDERS; COMBINED MODALITY THERAPY; DEVELOPMENTAL DISABILITIES; DISEASE TRANSMISSION, VERTICAL; HIV INFECTIONS; HIV-1; HUMANS; INFANT; MENTAL RETARDATION; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TESTS; PROGNOSIS;

EID: 33750469025     PISSN: 10804013     EISSN: 10982779     Source Type: Journal    
DOI: 10.1002/mrdd.20112     Document Type: Review

References (61)

1. Angelini L, Zibordi F, Triulzi F, et al. 2000. Age-dependent neurologic manifestations of HIV infection in childhood. Neurol Sci 21:135-42.
2. Armstrong FD. 2006. Neurodevelopment and chronic illness: Mechanisms of disease and treatment. Ment Retard Dev Disabil Res Rev 12:168-173.
3. Armstrong FD, Mulhern RK. 1999. Acute lymphoblastic leukemia and brain tumors. In: Brown RT, editor. Cognitive Aspects of Chronic Illness in Children. New York: Guilford Press, pp 47-77.
4. Armstrong FD, Seidel JF, Swales TP. 1993. Pediatric HIV infection: A neuropsychological and educational challenge. J Learn Disabil 26: 92-103.
5. Bachanas PJ, Kullgren KA, Schwartz KS, et al. 2001. Predictors of psychological adjustment in school-age children infected with HIV. Journal of Pediatr Psychol 26:343-352.
6. Belman AL, Diamond G, Dickson D, et al. 1988. Pediatric acquired immunodeficiency syndrome. Neurologic syndromes. Am J Dis Child 142, 29-35.
7. Belman AL, Muenz LR, Marcus JC, et al. 1996. Neurologic status of human immunodeficiency virus 1-infected infants and their controls: A prospective study from birth to 2 years. Mothers and infants cohort study. Pediatrics 98:1109-18.
8. Berrien VM, Salazar JC, Reynolds EMK, HIV Medication Adherence Intervention Group. 2004. Adherence to antiretroviral therapy in HIV- infected pediatric patients improves with home-based intensive nursing intervention. AIDS Patient Care STDS, 18, 355-363.
9. Bisiacchi PS, Suppiej A, Laverda, A. 2000. Neuropsychological evaluation of neurologically asymptomatic HIV- infected children. Brain Cogn 43:49-52.
10. Blanchette N, Smith ML, Fernandes-Penney A, et al. 2001. Cognitive and motor development in children with vertically transmitted HIV infection. Brain Cogn 46:50-53.
11. Boivin MJ, Green SD, Davies AG, et al. 1995. A preliminary evaluation of the cognitive and motor effects of pediatric HIV infection in Zairian children. Health Psychol 14:13-21.
12. Brouwers P, Belman AL, Epstein LG. 1994. CNS involvement: Manifestations, evaluation, and pathogenesis. In Pizzo PA, Wilfert CM, editors. Pediatric AIDS: The challenge of HIV infection in infants, children, and adolescents, 2nd ed. Baltimore: Williams and Wilkins. pp 433-455
13. Brouwers P, DeCarli C, Civitello L, et al. 1995. Correlation between computed tomographic brain scan abnormalities and neuropsychological functioning in children with symptomatic human immunodeficiency virus. Arch Neuro 52:39-44.
14. Brouwers P, van Engelen M, Lalonde F, et al. 2001. Abnormally increased semantic priming in children with symptomatic HIV-1 disease: Evidence for impaired development of semantics? J Int Neuropsychol Soc 7:491-501.
15. Butler KM, Husson RN, Balis FM, et al. 1991. Dideoxyinosine in children with symptomatic human immunodeficiency virus infection. N Engl J Med 324:137-144.
16. Chase C, Ware J, Hittelman J, et al. 2000. Early cognitive and motor development among infants born to women infected with human immunodeficiency virus. Women and infants transmission study group. Pediatrics 106:E25.
17. Centers for Disease Control and Prevention. AIDS Surveill Rep 8:13, 1996.
18. Cohen SE, Mundy T, Karassik B, et al. 1991. Neuropsychological functioning in Human Immunodeficiency Virus type 1 seropositive children infected through neonatal blood transfusion. Pediatrics 88:58-68.
19. Coplan J, Contello KA, Cunningham CK, et al. 1998. Early language development in children exposed to or infected with Human Immunodeficiency Virus. Pediatrics 102:E8.
20. Coscia JM, Christensen BK, Henry RR. 1997. Risk and resilience in the cognitive functioning of children born to HIV-1-infected mothers: A preliminary report. Pediatr AIDS HIV Infect 8:108-113.
21. Coscia JM, Christensen BK, Henry RR, et al. 2001. Effects of home environment, socioeconomic status, and health status on cognitive functioning in children with HIV-1 infection. J Pediatr Psychol 26:321-329.
22. DeCarli C, Fugate L, Falloon J, et al. 1991. Brain growth and cognitive improvement in children with human immunodeficiency virus-induced encephalopathy after 6 months of continuous infusion zidovudine therapy. J Acquir Immune Defic Syndr 4:585-592.
23. Drotar D, Olness K, Wiznitzer M, et al. 1997. Neurodevelopmental outcomes of Ugandan infants with Human Immunodeficiency Virus Type 1 infection. Pediatrics 100:E5.
24. Ferrando SJ, Rabkin JG, van Gorp W, et al. 2003. Longitudinal improvement in psychomotor processing speed is associated with potent combined antiretroviral therapy in HIV-1 infection. J Neuropsychiatr Clin Neurosci 15:208-214.
25. Fishkin PE, Armstrong FD, Routh DK, et al. 2000. Brief report: Relationship between HIV infection and WPPSI-R performance in preschool-age children. J Pediatr Psychol 25:347-51.
26. Fundaro C, Miccinesi N, Baldieri NF, et al. 1998. Cognitive impairment in school-age children with asymptomatic HIV infection. AIDS Patient Care STDS 12:135-140.
27. Gay CL, Armstrong FD, Cohen D, et al. 1995. The effects of HIV on cognitive and motor development in children born to HIV-seropositive women with no reported drug use: Birth to 24 months. Pediatrics 96:1078-1082.
28. Gigliotti F, Murante BL, Weinberg GA. 2001. Short course directly observed therapy to monitor compliance with antiretroviral therapy in human immunodeficiency virus-infected children. Pediatr Infect Dis J 20:716-718.
29. Gortmaker SL, Hughes M, Cervia J, et al. 2001. Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1. N Engl J Med, 345, 1522-1528.
30. Havens J, Whitaker A, Feldman J, et al. 1993. A controlled study of cognitive and language function in school-aged HIV-infected children. Ann N Y Acad Sci 693:249-251.
31. Instone SL. 2000. Perceptions of children with HIV infection when not told for so long: Implications for diagnosis disclosure. J Pediatr Health Care 14:235-243.
32. Jeremy RJ, Kim S, Nozyce M, et al. 2005. Neuropsychological functioning and viral load in stable antiretroviral therapy-experienced HIV-infected children. Pediatrics 115:380-7.
33. Kline MW. 2006. Perspectives on the pediatric HIV/AIDS pandemic: Catalyzing access of children to care and treatment. Pediatrics 117:1388-1393.
34. Knight WG, Mellins CA, Levenson RL Jr, et al. 2000. Brief report: Effects of pediatric HIV infection on mental and psychomotor development. J Pediatr Psychol 25:583-587.
35. Llorente AM, LoPresti CM, Satz P. 1997. Neuropsychological and neurobehavioral sequeale associated with pediatric HIV infection. In Reynolds CR, Fletcher-Janzen E, editors. Handbook of Clinical Child Neuropsychology, 2nd ed. New York: Plenum, pp 634-650.
36. Loveland KA, Stehbens J, Contant C, Bordeaux JD, et al. 1994. Hemophilia growth and development study: Baseline neurodevelopmental findings. J Pediatr Psychol 19:223-239.
37. Lyon ME, Trexler C, Akpan-Townsend C, et al. 2003. A family group approach to increasing adherence to therapy ill HIV-infected youths: Results of a pilot project. AIDS Patient Care STDS 17:299-308.
38. Mellins CA, Levenson RL Jr, Zawadzki R, et al. 1994. Effects of pediatric HIV infection and prenatal drug exposure on mental and psychomotor development. J Pediatr Psychol 19:617-627.
39. Mialky E, Vagnoni J, Rutstein R. 2001. School-age children with perinatally acquired HIV infection: Medical and psychosocial issues in a Philadelphia cohort. AIDS Patient Care STDS 15:575-579.
40. Miller CR. 1997. Pediatric aspects of AIDS. Radiol Clin North Am 35:1191-221.
41. Mintz M. 1996. Neurological and developmental problems in pediatric HIV infection. J Nutr 126:26635-26735.
42. Mintz M. 1999. Clinical features and treatment interventions for Human Immunodeficiency Virus-associated neurologic disease in children. Semin Neurol 19:165-176.
43. Mitchell W. 2001. Neurological and developmental effects of HIV and AIDS in children and adolescents. Ment Retard Dev Disabil Res Reviews 7:211-216.
44. Moss H, Bose S, Wolters P, et al. 1998. A preliminary study of factors associated with psychological adjustment and disease course in school-age children infected with the Human Immunodeficiency Virus. J Dev Behav Pediatr 19:18-25.
45. Moss HA, Wolters PL, Brouwers P, et al. 1996. Impairment of expressive behavior in pediatric HIV-infected patients with evidence of CNS disease. J Pediatr Psychol 21:379-400.
46. Nozyce M, Hittelman J, Muenz L, et al. 1994. Effect of perinatally acquired human immunodeficiency virus infection on neurodevelopment in children during the first two years of life. Pediatrics 94:883-91.
47. Nozyce ML, Lee SS, Wiznia A, et al. 2006. A behavioral and cognitive profile of clinically stable HIV-infected children. Pediatrics 117:763-770.
48. Parsons GN, Siberry GK, Parsons JK, et al. 2006. Multidisciplinary, inpatient directly observed therapy for HIV-1-infected children and adolescents failing HAART: A retrospective study. AIDS Patient Care STDS 20:275-284.
49. Pearson DA, McGrath NM, Nozyce M, et al. 2000. Predicting HIV disease progression in children using measures of neuropsychological and neurological functioning. Pediatric AIDS Clinical Trials 152 Study Team. Pediatrics 106:e76.
50. Pizzo PA, Eddy J, Falloon J, et al. 1988. Effect of continuous intravenous infusion of zidovudine (AZT) in children with symptomatic HIV infection. N Engl J Med 319:889-96.
51. Pontali E, Feasi M, Toscanini F, et al. 2001. Adherence to combination antiretroviral treatment in children. HIV Clin Trials 2:466-473.
52. Reikert K, Drotar D. 2002. The beliefs about medication scale: Development, reliability, and validity. J Clin Psychol Med Settings 9:177-184.
53. Roberts GM, Wheeler JG, Tucker NC, et al. 2004. Nonadherence with pediatric human immunodeficiency virus therapy as medical neglect. Pediatrics 114:346-353.
54. Robertson KR, Robertson WT, Ford S, et al. 2004. Highly active antiretroviral therapy improves neurocognitive functioning. J Acquir Immune Defic Syndr 36:562-567.
55. Safriel YI, Haller JO, Lefton DR, et al. 2000. Imaging of the brain in the HIV-positive child. Pediatr Radiol 30:725-32.
56. Shanbhag MC, Rutstein RM, Zaoutis T, et al. 2005. Neurocognitive functioning in pediatric human immunodeficiency virus infection: Effects of combined therapy. Arch Pediatr Adolesc Med 159:651-6.
57. Simpson DM, Berger JR. 1996. Neurologic manifestations of HIV infection. Med Clin North Am 80:1363-1394.
58. Tamula MA, Wolters PL, Walsek C, et al. 2003. Cognitive decline with immunologic and virologic stability in four children with human immunodeficiency virus disease. Pediatrics 112:679-84.
59. Tardieu M, Mayaux MJ, Seibel N, et al. 1995. Cognitive assessment of school-age children infected with maternally transmitted human immunodeficiency virus type 1. J Pediatr 126:375-379.
60. Wolters PL, Brouwers P, Civitello L, et al 1997. Receptive and expressive language function of children with symptomatic HIV infection and relationship with disease parameters: A longitudinal 24-month follow-up study. AIDS 11:1135-1144.
61. Wolters PL, Brouwers P, Moss HA, et al. 1994. Adaptive behavior of children with symptomatic HIV infection before and after zidovudine therapy. J Pediatr Psychol 19:47-61.